ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI..........................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0831912A119980401EP96916903.01996053119971223enenen1995045913419950602US1998040119981419980401199814

A61L 27/ 00 A I

A61K 9/ 00 A I

A61K 9/ 10 A I

A61K 9/ 20 A I

A61K 31/ 19 A I

A61K 31/ 57 A I

A61K 31/ 70 A I

A61K 47/ 34 A I

A61P 29/ 00 A I

A61P 31/ 12 A I

enIMPROVED FORMULATION FOR CONTROLLED RELEASE OF DRUGS BY COMBINING HYDROPHILIC AND HYDROPHOBIC AGENTSfrAMELIORATION APPORTEE A UNE FORMULATION DESTINEE A LA LIBERATION CONTROLEE DE MEDICAMENTS PAR COMBINAISON D'AGENTS HYDROPHILES ET HYDROPHOBESdeVERBESSERTE FORMULIERUNG ZUR GESTEUERTEN ARZNEISTOFFFREISETZUNG DURCH KOMBINATION HYDROPHILER UND HYDROPHOBER STOFFE04019281.704019466.4147718705027625.2163716410012665.52298353OCULEX PHARMACEUTICALS, INC.Building 1, 3180 Porter DrivePalo Alto, CA 94304-1212USKOCHINKE, Frank3413 Antonacci CourtSan Jose, CA 95148USWONG, Vernon10908 Rosemont DriveRockville, MD 20852USAllard, Susan Joyce, et alBOULT WADE TENNANT, 27 Furnival StreetLondon EC4A 1PQGBATBECHDEDKESFIFRGBGRIEITLILUMCNLPTSEUS199600825019960531enWO199603817419961205199701